Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| West Nile virus | 10 | 2015 | 78 | 2.540 |
Why?
|
| Testis | 6 | 2025 | 207 | 2.330 |
Why?
|
| West Nile Fever | 9 | 2015 | 68 | 1.970 |
Why?
|
| Sertoli Cells | 3 | 2019 | 43 | 1.680 |
Why?
|
| Blood-Brain Barrier | 5 | 2014 | 173 | 1.240 |
Why?
|
| Neutrophils | 2 | 2025 | 145 | 1.010 |
Why?
|
| Tight Junctions | 3 | 2012 | 27 | 0.970 |
Why?
|
| Dexamethasone | 1 | 2025 | 55 | 0.880 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 1596 | 0.790 |
Why?
|
| Membrane Proteins | 5 | 2012 | 561 | 0.760 |
Why?
|
| Lung | 2 | 2025 | 492 | 0.730 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 35 | 0.660 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 209 | 0.630 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2019 | 29 | 0.600 |
Why?
|
| Virus Internalization | 1 | 2019 | 36 | 0.600 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.580 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2017 | 32 | 0.560 |
Why?
|
| Blood-Testis Barrier | 1 | 2017 | 3 | 0.550 |
Why?
|
| Organoids | 1 | 2018 | 37 | 0.550 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 257 | 0.530 |
Why?
|
| Leukocytes | 2 | 2014 | 80 | 0.520 |
Why?
|
| Brain | 7 | 2015 | 1472 | 0.510 |
Why?
|
| Mice | 10 | 2025 | 6644 | 0.510 |
Why?
|
| Cells, Cultured | 6 | 2019 | 1621 | 0.470 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 33 | 0.460 |
Why?
|
| Adenosine | 1 | 2015 | 62 | 0.450 |
Why?
|
| Lung Injury | 2 | 2025 | 18 | 0.440 |
Why?
|
| Cell Adhesion Molecules | 3 | 2017 | 83 | 0.440 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 263 | 0.440 |
Why?
|
| Endothelial Cells | 4 | 2014 | 329 | 0.430 |
Why?
|
| JC Virus | 4 | 2007 | 23 | 0.430 |
Why?
|
| Humans | 23 | 2025 | 43102 | 0.400 |
Why?
|
| Animals | 14 | 2025 | 16992 | 0.400 |
Why?
|
| Cell Adhesion | 1 | 2014 | 238 | 0.400 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2012 | 16 | 0.370 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2012 | 26 | 0.370 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 116 | 0.360 |
Why?
|
| Immunity, Innate | 1 | 2013 | 171 | 0.360 |
Why?
|
| Astrocytes | 2 | 2010 | 244 | 0.350 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 95 | 0.350 |
Why?
|
| Cell Migration Inhibition | 1 | 2011 | 5 | 0.340 |
Why?
|
| Nitrobenzenes | 1 | 2010 | 19 | 0.340 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2010 | 27 | 0.330 |
Why?
|
| Dinoprostone | 1 | 2010 | 64 | 0.330 |
Why?
|
| Male | 10 | 2025 | 23409 | 0.330 |
Why?
|
| Interferon-alpha | 4 | 2017 | 43 | 0.320 |
Why?
|
| Sulfonamides | 1 | 2010 | 91 | 0.320 |
Why?
|
| Calcium Signaling | 1 | 2011 | 107 | 0.320 |
Why?
|
| Selenium | 2 | 2011 | 155 | 0.320 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 49 | 0.310 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 140 | 0.300 |
Why?
|
| Selenoproteins | 1 | 2011 | 155 | 0.290 |
Why?
|
| Cytokines | 4 | 2014 | 678 | 0.280 |
Why?
|
| Calcium | 1 | 2011 | 491 | 0.270 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 665 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 1869 | 0.260 |
Why?
|
| Vero Cells | 3 | 2015 | 112 | 0.250 |
Why?
|
| Virus Replication | 5 | 2015 | 318 | 0.240 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 704 | 0.240 |
Why?
|
| Interferons | 1 | 2005 | 40 | 0.240 |
Why?
|
| Deoxyribonuclease I | 1 | 2025 | 26 | 0.230 |
Why?
|
| Inflammation | 3 | 2025 | 758 | 0.230 |
Why?
|
| Cell Line | 4 | 2018 | 1410 | 0.220 |
Why?
|
| Contraceptive Agents | 1 | 2004 | 13 | 0.220 |
Why?
|
| Neutrophil Infiltration | 1 | 2024 | 28 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 38 | 0.210 |
Why?
|
| Testosterone | 1 | 2025 | 211 | 0.200 |
Why?
|
| Bystander Effect | 1 | 2023 | 15 | 0.200 |
Why?
|
| Vaccines | 1 | 2004 | 65 | 0.200 |
Why?
|
| Lipids | 1 | 2025 | 256 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 187 | 0.190 |
Why?
|
| Proteins | 1 | 2005 | 382 | 0.190 |
Why?
|
| Spermatozoa | 1 | 2004 | 214 | 0.190 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 1070 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 166 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2025 | 460 | 0.150 |
Why?
|
| Virulence | 2 | 2018 | 246 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2013 | 1035 | 0.140 |
Why?
|
| Claudins | 1 | 2017 | 8 | 0.140 |
Why?
|
| Immunity | 2 | 2021 | 61 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 146 | 0.130 |
Why?
|
| Dengue Virus | 1 | 2017 | 96 | 0.120 |
Why?
|
| Dengue | 1 | 2017 | 107 | 0.120 |
Why?
|
| Chemokine CCL3 | 1 | 2015 | 14 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 384 | 0.120 |
Why?
|
| Antibodies, Viral | 3 | 2013 | 306 | 0.120 |
Why?
|
| Interleukin-1beta | 2 | 2013 | 75 | 0.110 |
Why?
|
| Chemokines | 2 | 2013 | 96 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 760 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 46 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 234 | 0.110 |
Why?
|
| E-Selectin | 1 | 2014 | 23 | 0.110 |
Why?
|
| DNA Primers | 2 | 2013 | 294 | 0.110 |
Why?
|
| Permeability | 1 | 2014 | 67 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2014 | 59 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2014 | 124 | 0.100 |
Why?
|
| Macrophages | 1 | 2017 | 529 | 0.100 |
Why?
|
| Caspase 1 | 1 | 2013 | 16 | 0.100 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Monocytes | 1 | 2014 | 277 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2013 | 132 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 161 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2013 | 411 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 458 | 0.090 |
Why?
|
| Peritonitis | 1 | 2011 | 11 | 0.090 |
Why?
|
| Receptors, Peptide | 1 | 2011 | 24 | 0.080 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 2 | 2007 | 7 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2011 | 74 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2013 | 883 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 934 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 107 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 108 | 0.080 |
Why?
|
| Dipeptides | 1 | 2009 | 31 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 2676 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 278 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 54 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2012 | 536 | 0.080 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2008 | 14 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1271 | 0.070 |
Why?
|
| Neuroglia | 2 | 2007 | 133 | 0.070 |
Why?
|
| Culture Media | 1 | 2008 | 96 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 386 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2009 | 206 | 0.070 |
Why?
|
| Interferon-beta | 1 | 2007 | 9 | 0.070 |
Why?
|
| Gene Expression | 1 | 2010 | 701 | 0.070 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2007 | 15 | 0.070 |
Why?
|
| Neurons | 2 | 2014 | 1263 | 0.060 |
Why?
|
| Base Sequence | 2 | 2007 | 983 | 0.060 |
Why?
|
| Hemagglutination Tests | 1 | 2006 | 4 | 0.060 |
Why?
|
| Sperm Agglutination | 1 | 2004 | 1 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 310 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2005 | 74 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2004 | 39 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 532 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 455 | 0.050 |
Why?
|
| Liposomes | 1 | 2025 | 132 | 0.050 |
Why?
|
| Cricetinae | 1 | 2004 | 241 | 0.050 |
Why?
|
| Rabbits | 1 | 2004 | 278 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 1003 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 1180 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1542 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 74 | 0.040 |
Why?
|
| Apoptosis | 1 | 2008 | 1568 | 0.040 |
Why?
|
| DNA, Viral | 2 | 2007 | 311 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Female | 2 | 2025 | 24698 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 127 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 204 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2012 | 76 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 75 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 40 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 101 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 286 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 386 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 368 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2012 | 182 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 695 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 348 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 429 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 655 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2010 | 136 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2007 | 18 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 2007 | 22 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 113 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2006 | 75 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2007 | 321 | 0.010 |
Why?
|